Drug intelligence / Profile preview

albendazole + vitamin a

Development stage
Unknown
Lead developer
Sichuan Pearl Pharmaceutical
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Albendazole + vitamin A is a combination therapy consisting of albendazole, a benzimidazole anthelmintic, and vitamin A (retinol), a fat-soluble micronutrient. Albendazole acts by inhibiting microtubule polymerization in helminths, leading to impaired glucose uptake and parasite death. Vitamin A is essential for vision, immune function, and cellular growth; it also plays a role in iron metabolism. The combination has been studied primarily as an intervention for pre-school children with anemia or at risk of parasitic infections and micronutrient deficiencies. Clinical studies show that co-administration improves serum retinol levels, iron status (ferritin), hemoglobin concentration, and reduces the prevalence of both vitamin A deficiency and iron deficiency more effectively than either agent alone[1][3][5]. This approach is used as part of public health strategies in regions with high rates of helminth infection and nutritional deficiencies.

02

Targets

TUBB (Tubulin (alpha and beta subunits))RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on albendazole + vitamin a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on albendazole + vitamin a.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call